APA (7th ed.) Citation

Ma, X., Kang, H., Dai, Z., Ma, L., Jin, Y., & Wang, X. (2015). Impact of the IGFBP3 A-202C polymorphism on susceptibility and clinicopathologic features of breast cancer. Biomedicine & pharmacotherapy, 71, 108-111. https://doi.org/10.1016/j.biopha.2015.02.018

Chicago Style (17th ed.) Citation

Ma, Xiaobin, Huafeng Kang, Zhijun Dai, Li Ma, Yaofeng Jin, and Xijing Wang. "Impact of the IGFBP3 A-202C Polymorphism on Susceptibility and Clinicopathologic Features of Breast Cancer." Biomedicine & Pharmacotherapy 71 (2015): 108-111. https://doi.org/10.1016/j.biopha.2015.02.018.

MLA (9th ed.) Citation

Ma, Xiaobin, et al. "Impact of the IGFBP3 A-202C Polymorphism on Susceptibility and Clinicopathologic Features of Breast Cancer." Biomedicine & Pharmacotherapy, vol. 71, 2015, pp. 108-111, https://doi.org/10.1016/j.biopha.2015.02.018.